Blake Mycoskie

Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly 19 million in beneficially owned shares of Cybin Inc. (NYSE: CYBN). The considerably large acquisition puts Cybin in the limelight with credibility...

Several days prior to the FDA’s issuance of the draft guidance for clinical trials with psychedelics, Blake Mycoskie, founder of Toms Shoes pledged the new goal of donating and investing a total of $100 million, 25% of his stated net worth, on psychedelic therapies...